| Stage | ECVT | % of rev | BGC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $250M | 100.00% | $846M | 100.00% | BGC ×3.38 |
| Gross profit | $50M | 19.94% | $846M | 100.00% | BGC +80.1pp |
| Operating income | $19M | 7.75% | $72M | 8.50% | BGC +0.8pp |
| Pre-tax income | $15M | 5.96% | $99M | 11.70% | BGC +5.7pp |
| Net income | $8M | 3.15% | $69M | 8.14% | BGC +5.0pp |
| Stage | ECVT | BGC | Gap · A − B |
|---|---|---|---|
| Revenue | $250M100.00% | $846M100.00% | BGC ×3.38 |
| Gross profit | 19.94%$50M | 100.00%$846M | BGC +80.1pp |
| Operating income | 7.75%$19M | 8.50%$72M | BGC +0.8pp |
| Pre-tax income | 5.96%$15M | 11.70%$99M | BGC +5.7pp |
| Net income |
| 3.15%$8M |
| 8.14%$69M |
| BGC +5.0pp |
No disclosed counterparties: BGC.
None